Brief: Gensight Biologics Says It Is Financed Until End Of 2020

Gensight Biologics SA

21/04/2020 06:56

April 21 (Reuters) - GENSIGHT BIOLOGICS SA  SIGHT.PA :
    * GENSIGHT BIOLOGICS' CASH AND CASH EQUIVALENTS TOTALED EUR
12.8
MILLION AS OF MARCH 31, 2020, COMPARED TO EUR 19.2 MILLION AS OF
DECEMBER 31, 2019.
    * IS FINANCED UNTIL END OF 2020 AND IS INVESTIGATING OTHER
FINANCING OPTIONS THROUGH DEBT OR EQUITY
    * EXPECTS REIMBURSEMENT IN 2020 OF 2019 RESEARCH TAX CREDIT
FOR AN
AMOUNT OF EUR 4.2 MILLION.

Source text for Eikon:  ID:nBw1DL0lZa 
Further company coverage:  SIGHT.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))